Smith & Nephew Plc
3 April 2002
3 April 2002
SMITH & NEPHEW PLC
STRONG SALES GROWTH CONTINUES FOR SMITH & NEPHEW
Smith & Nephew, the advanced medical devices group, has seen sales growth in the
first quarter of 2002 continue at the strong level achieved during 2001,
Chairman Dudley Eustace told shareholders at the company's AGM today.
Mr Eustace said that Smith & Nephew's chosen markets are growing robustly. 'We
are well positioned to benefit from the increasing demand for easier-to-use,
more efficient products, and intend to maintain the momentum we have developed
in recent years. Our emphasis on achieving strong organic growth will continue
by increasing our sales teams, running our businesses more efficiently, and
ensuring we maintain the pace of launching innovative new products. We will
also seek to acquire businesses or technologies which strengthen our long-term
prospects and underpin our drive for shareholder value.'
He said that in 2001 the group's three major businesses all improved their sales
and profit performance. Orthopaedics maintained its position as one of the
fastest growing orthopaedics companies, growing at almost twice the market rate.
Endoscopy reinforced its position as world No 1 in minimally invasive surgery
of the joints, with the knee ligament repair business growing by 15%. Wound
Management consolidated its position as world leader in the advanced treatment
of hard to heal wounds, integrating two significant acquisitions.
Enquiries:
Chris O'Donnell, Chief Executive Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
Peter Hooley, Finance Director Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
Margaret Stewart, Group Director, Corporate Affairs Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
David Yates Tel: +44 (0) 20 7831 3113
Financial Dynamics
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.